+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sacubitril Valsartan Sodium Tablets Market - Global Forecast 2026-2032- Product Image
Sacubitril Valsartan Sodium Tablets Market - Global Forecast 2026-2032- Product Image
New

Sacubitril Valsartan Sodium Tablets Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 186 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 6079763
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Sacubitril Valsartan Sodium Tablets play a central role in current heart failure therapy as the market shifts toward advanced supply resilience, regulatory rigor, and streamlined patient access. As global priorities evolve, their relevance for senior healthcare and manufacturing decision-makers grows accordingly.

Market Snapshot: Sacubitril Valsartan Sodium Tablets Market Overview

The Sacubitril Valsartan Sodium Tablets market is experiencing robust expansion, with the global market value forecast to grow from USD 10.22 billion in 2025 to USD 10.98 billion in 2026, ultimately reaching USD 17.28 billion by 2032. This sustained advancement, driven by a 7.78% compound annual growth rate (CAGR), underscores increasing clinical adoption, wider access initiatives, and strategic supply chain investments worldwide. Manufacturers and stakeholders are adapting to shifting care pathways, while payers and providers emphasize affordable access and operational continuity across all major geographies.

Scope & Segmentation

  • Product Types: Tablets engineered to support differentiated adherence profiles, improve ease of administration, and integrate smoothly with uniform prescribing standards.
  • Dosage Strengths: Multiple titration options designed to meet variable clinical guidelines and patient-specific tolerance, directly addressing the needs of diverse formularies and prescribers.
  • Distribution Channels: Channels include hospital procurement, retail pharmacies, wholesale distributors, and community outpatient settings. Each requires tailored solutions for contracting, service levels, and channel performance.
  • End-User Segments: Specialized cardiology centers, hospital networks, community providers, and outpatient clinics, all demanding evidence-driven support and tailored solutions for day-to-day implementation.
  • Geographic Regions: Americas, Europe, Middle East & Africa, and Asia-Pacific reflect different regulatory frameworks, reimbursement systems, and operational conditions that influence market entry and sustainability.
  • Technology & Manufacturing: Adoption of alternative ingredient sourcing, oversight for contract manufacturing, resilient process design, and serialization for compliance assurance help address complex supply expectations.

Key Takeaways for Decision-Makers

  • Clinical care pathways are becoming increasingly standardized, raising both the costs and operational hurdles of therapy switches. This enhances the strategic value of solutions deeply embedded within institutional workflows.
  • Payers demand greater clarity around pharmacoeconomic performance and patient adherence. Clearer evidence delivery and proactive patient engagement are essential for successful reimbursement strategies.
  • Procurement and regulatory authorities require demonstrable commitment to quality, multi-source strategies, and strict deviation controls. Meeting these criteria directly affects contract terms and long-term commercial resilience.
  • Organizations that synchronize supply planning with market access are more resilient to policy changes and global market fluctuations, fostering continuity.
  • Competitive positioning improves with agile tender execution, strong provider relationships, and anticipation of regulatory or operational shifts in diverse regional settings.

Tariff Impact and Supply Chain Strategy

Recent United States tariff policies for 2025 introduce notable complexity for global manufacturers of Sacubitril Valsartan Sodium Tablets, particularly those dependent on cross-border manufacturing and ingredient sourcing. These tariffs can drive up landed costs, extend procurement cycles, and require rapid contract adjustments, making it essential for companies to maintain diverse supplier networks and dual sourcing strategies. To minimize disruption and control costs, organizations are increasingly investing in localized supply chains, though this approach demands careful management of operational complexity and capital allocation. These trends are shaping how supply chain resilience is valued across the entire sector.

Regional Dynamics

  • Americas: The market is defined by strong payer oversight, persistent focus on channel continuity, and prioritization of operational support infrastructures for heart failure therapies.
  • Europe, Middle East & Africa: Markets here are characterized by a variety of reimbursement and procurement systems, necessitating adaptable regulatory approaches and regionally tailored access plans.
  • Asia-Pacific: Growth stems from increasing diagnosis rates, expanding investments in healthcare infrastructure, and ongoing requirements for provider education. Consistent drug supply remains an overarching challenge and need.

Methodology & Data Sources

The report compiles insights from rigorous secondary research and targeted interviews with subject matter experts and operational executives across supply chain, clinical, and regulatory functions. Data triangulation and scenario analysis ensure precise, actionable findings, all rigorously segmented to support strategic decision-making.

Sacubitril Valsartan Sodium Tablets Market: Why This Report Matters

  • Guides senior leaders in identifying operational, supply, and policy risks, giving them a foundation for robust continuity planning and contract strategy.
  • Facilitates portfolio management by mapping the interface between product design, channel choice, and shifting regional demands.
  • Delivers concise, decision-ready intelligence for commercial, procurement, and regulatory teams in a fast-evolving therapeutic landscape.

Conclusion

Sacubitril Valsartan Sodium Tablets compete in a market shaped by regulatory demands, operational challenges, and evolving distribution models. Senior leaders who prioritize resilient supply systems and adaptive regional strategies can position their organizations for sustained progress in cardiovascular care.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Sacubitril Valsartan Sodium Tablets Market, by Product Type
8.1. Branded
8.2. Generic
9. Sacubitril Valsartan Sodium Tablets Market, by Strength
9.1. 24/26 mg
9.2. 49/51 mg
9.3. 97/103 mg
10. Sacubitril Valsartan Sodium Tablets Market, by Dosage Form
10.1. Film-Coated Tablet
10.2. Tablet
11. Sacubitril Valsartan Sodium Tablets Market, by Distribution Channel
11.1. Offline
11.2. Online
12. Sacubitril Valsartan Sodium Tablets Market, by End-User
12.1. Clinic
12.2. Home Care
12.3. Hospital
13. Sacubitril Valsartan Sodium Tablets Market, by Region
13.1. Americas
13.1.1. North America
13.1.2. Latin America
13.2. Europe, Middle East & Africa
13.2.1. Europe
13.2.2. Middle East
13.2.3. Africa
13.3. Asia-Pacific
14. Sacubitril Valsartan Sodium Tablets Market, by Group
14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO
15. Sacubitril Valsartan Sodium Tablets Market, by Country
15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea
16. United States Sacubitril Valsartan Sodium Tablets Market
17. China Sacubitril Valsartan Sodium Tablets Market
18. Competitive Landscape
18.1. Market Concentration Analysis, 2025
18.1.1. Concentration Ratio (CR)
18.1.2. Herfindahl Hirschman Index (HHI)
18.2. Recent Developments & Impact Analysis, 2025
18.3. Product Portfolio Analysis, 2025
18.4. Benchmarking Analysis, 2025
18.5. Aspen Pharmacare Holdings Limited
18.6. Aurobindo Pharma Limited
18.7. Cipla Limited
18.8. Dr. Reddy's Laboratories Ltd.
18.9. Glenmark Pharmaceuticals Ltd.
18.10. Hetero Labs Limited
18.11. Lupin Limited
18.12. MacLeod's Pharmaceuticals Ltd.
18.13. MSN Laboratories Private Limited
18.14. Mylan N.V.
18.15. Natco Pharma Limited
18.16. Novartis AG
18.17. Orion Corporation
18.18. Pfizer Inc.
18.19. Sandoz International GmbH
18.20. Sun Pharmaceutical Industries Ltd.
18.21. Teva Pharmaceutical Industries Ltd.
18.22. Torrent Pharmaceuticals Ltd.
18.23. Zydus Lifesciences Limited
List of Figures
FIGURE 1. GLOBAL SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL SACUBITRIL VALSARTAN SODIUM TABLETS MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY STRENGTH, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY DOSAGE FORM, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY END-USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. UNITED STATES SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 13. CHINA SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY BRANDED, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY BRANDED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY BRANDED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY GENERIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY GENERIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY GENERIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY STRENGTH, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY 24/26 MG, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY 24/26 MG, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY 24/26 MG, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY 49/51 MG, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY 49/51 MG, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY 49/51 MG, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY 97/103 MG, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY 97/103 MG, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY 97/103 MG, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY FILM-COATED TABLET, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY FILM-COATED TABLET, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY FILM-COATED TABLET, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY TABLET, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY TABLET, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY TABLET, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY OFFLINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY CLINIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY CLINIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY CLINIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY HOME CARE, BY REGION, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY HOME CARE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY HOME CARE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY HOSPITAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY HOSPITAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. AMERICAS SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 45. AMERICAS SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 46. AMERICAS SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY STRENGTH, 2018-2032 (USD MILLION)
TABLE 47. AMERICAS SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 48. AMERICAS SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 49. AMERICAS SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 50. NORTH AMERICA SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 51. NORTH AMERICA SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 52. NORTH AMERICA SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY STRENGTH, 2018-2032 (USD MILLION)
TABLE 53. NORTH AMERICA SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 54. NORTH AMERICA SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 55. NORTH AMERICA SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 56. LATIN AMERICA SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 57. LATIN AMERICA SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 58. LATIN AMERICA SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY STRENGTH, 2018-2032 (USD MILLION)
TABLE 59. LATIN AMERICA SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 60. LATIN AMERICA SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 61. LATIN AMERICA SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 62. EUROPE, MIDDLE EAST & AFRICA SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 63. EUROPE, MIDDLE EAST & AFRICA SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 64. EUROPE, MIDDLE EAST & AFRICA SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY STRENGTH, 2018-2032 (USD MILLION)
TABLE 65. EUROPE, MIDDLE EAST & AFRICA SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 66. EUROPE, MIDDLE EAST & AFRICA SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 67. EUROPE, MIDDLE EAST & AFRICA SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 68. EUROPE SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 69. EUROPE SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 70. EUROPE SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY STRENGTH, 2018-2032 (USD MILLION)
TABLE 71. EUROPE SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 72. EUROPE SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 73. EUROPE SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 74. MIDDLE EAST SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 75. MIDDLE EAST SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 76. MIDDLE EAST SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY STRENGTH, 2018-2032 (USD MILLION)
TABLE 77. MIDDLE EAST SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 78. MIDDLE EAST SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 79. MIDDLE EAST SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 80. AFRICA SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 81. AFRICA SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 82. AFRICA SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY STRENGTH, 2018-2032 (USD MILLION)
TABLE 83. AFRICA SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 84. AFRICA SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 85. AFRICA SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 86. ASIA-PACIFIC SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 87. ASIA-PACIFIC SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 88. ASIA-PACIFIC SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY STRENGTH, 2018-2032 (USD MILLION)
TABLE 89. ASIA-PACIFIC SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 90. ASIA-PACIFIC SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 91. ASIA-PACIFIC SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 93. ASEAN SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 94. ASEAN SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 95. ASEAN SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY STRENGTH, 2018-2032 (USD MILLION)
TABLE 96. ASEAN SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 97. ASEAN SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 98. ASEAN SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 99. GCC SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 100. GCC SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 101. GCC SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY STRENGTH, 2018-2032 (USD MILLION)
TABLE 102. GCC SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 103. GCC SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 104. GCC SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 105. EUROPEAN UNION SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 106. EUROPEAN UNION SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 107. EUROPEAN UNION SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY STRENGTH, 2018-2032 (USD MILLION)
TABLE 108. EUROPEAN UNION SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 109. EUROPEAN UNION SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 110. EUROPEAN UNION SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 111. BRICS SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 112. BRICS SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 113. BRICS SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY STRENGTH, 2018-2032 (USD MILLION)
TABLE 114. BRICS SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 115. BRICS SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 116. BRICS SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 117. G7 SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 118. G7 SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 119. G7 SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY STRENGTH, 2018-2032 (USD MILLION)
TABLE 120. G7 SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 121. G7 SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 122. G7 SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 123. NATO SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 124. NATO SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 125. NATO SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY STRENGTH, 2018-2032 (USD MILLION)
TABLE 126. NATO SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 127. NATO SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 128. NATO SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 129. GLOBAL SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 130. UNITED STATES SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 131. UNITED STATES SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 132. UNITED STATES SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY STRENGTH, 2018-2032 (USD MILLION)
TABLE 133. UNITED STATES SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 134. UNITED STATES SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 135. UNITED STATES SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 136. CHINA SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 137. CHINA SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 138. CHINA SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY STRENGTH, 2018-2032 (USD MILLION)
TABLE 139. CHINA SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 140. CHINA SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 141. CHINA SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Sacubitril Valsartan Sodium Tablets market report include:
  • Aspen Pharmacare Holdings Limited
  • Aurobindo Pharma Limited
  • Cipla Limited
  • Dr. Reddy's Laboratories Ltd.
  • Glenmark Pharmaceuticals Ltd.
  • Hetero Labs Limited
  • Lupin Limited
  • MacLeod's Pharmaceuticals Ltd.
  • MSN Laboratories Private Limited
  • Mylan N.V.
  • Natco Pharma Limited
  • Novartis AG
  • Orion Corporation
  • Pfizer Inc.
  • Sandoz International GmbH
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Torrent Pharmaceuticals Ltd.
  • Zydus Lifesciences Limited

Table Information

Report AttributeDetails
No. of Pages186
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 10.98 Billion
Forecasted Market Value ( USD ) by 2032 $ 17.28 Billion
Compound Annual Growth Rate7.7%
Regions CoveredGlobal
No. of Companies Mentioned20

Related Topics

Related Reports

Sacubitril Valsartan Sodium Drugs Market - Global Forecast 2026-2032 - Product Image

Sacubitril Valsartan Sodium Drugs Market - Global Forecast 2026-2032

  • Report
  • 192 Pages
  • Global
From
Valsartan Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Product Type - Product Image

Valsartan Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Product Type

  • Report
  • 105 Pages
  • Global
From
Valsartan (CAS 137862-53-4) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029 - Product Image

Valsartan (CAS 137862-53-4) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029

  • Report
  • 50 Pages
  • Global
From
Angiotensin Receptor Blockers (ARBs) Market Report 2025 - Product Image

Angiotensin Receptor Blockers (ARBs) Market Report 2025

  • Report
  • 250 Pages
  • Global
From
Chronic Heart Failure Pipeline Analysis Report 2025 - Product Image

Chronic Heart Failure Pipeline Analysis Report 2025

  • Report
  • 200 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.